Santa Cruz Biotechnology features a diverse variety of CD60b monoclonal antibodies for research applications. CD60b monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD60b, also known as the lymphocyte activation antigen, plays a crucial role in immune response regulation and cell signaling. CD60b is involved in the activation and proliferation of T cells, making it significant in studies related to autoimmune diseases and cancer immunology. Understanding CD60b function is essential for developing targeted therapies and advancing our knowledge of immune system dynamics. CD60b monoclonal antibodies enable precise detection and analysis of immune cell interactions and signaling pathways. CD60b monoclonal antibodies support investigation of T cell development, activation mechanisms, and immune response modulation. CD60b monoclonal antibodies from Santa Cruz Biotechnology empower researchers to advance scientific understanding of immune system function and potential therapeutic approaches.